ClinicalTrials.gov
ClinicalTrials.gov Menu

Thyroid Autoimmunity and Reproductive Failure in Danish Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02912442
Recruitment Status : Not yet recruiting
First Posted : September 23, 2016
Last Update Posted : September 23, 2016
Sponsor:
Information provided by (Responsible Party):
Ulla Feldt-Rasmussen, Rigshospitalet, Denmark

Brief Summary:
The present Ph.D.-study investigates the mechanisms behind the association between thyroid autoimmunity and reproductive failure.

Condition or disease
Thyroid Infertility Autoantibodies Autoimmunity Pregnancy Loss

Study Type : Observational
Estimated Enrollment : 1200 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Thyroid Autoimmunity and Reproductive Failure - a Study of Autoimmunity in Association With Treatment Outcome in Infertile Danish Women With Infertility or Recurrent Miscarriages.
Study Start Date : December 2016
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2020

Resource links provided by the National Library of Medicine

Drug Information available for: Thyroid

Group/Cohort
Infertile women study 1
Infertile women study 2
Repeated pregnancy loss



Primary Outcome Measures :
  1. Live birth [ Time Frame: 2011-2015 ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Women referred to the infertility clinic
Criteria

Inclusion Criteria:

  • Women followed in the Fertility Clinic

Exclusion Criteria:

  • Pregnancy at time of blood sampling. Immune-suppressive ⁄modulatory treatments. Women referred for oocyt donation, genetic testing, and hepatitis and HIV-positivity

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02912442


Contacts
Contact: Ulla Feldt-Rasmussen, Proff., DMSc ulla.feldt-rasmussen@dadlnet.dk

Locations
Denmark
Rigshospitalet
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark

Responsible Party: Ulla Feldt-Rasmussen, Professor, DMSc, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT02912442     History of Changes
Other Study ID Numbers: THY-FER-IMM
First Posted: September 23, 2016    Key Record Dates
Last Update Posted: September 23, 2016
Last Verified: September 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: Undecided

Keywords provided by Ulla Feldt-Rasmussen, Rigshospitalet, Denmark:
thyroid
infertility
autoimmunity
pregnancy loss
autoantibodies

Additional relevant MeSH terms:
Thyroid Diseases
Infertility
Autoimmune Diseases
Endocrine System Diseases
Genital Diseases, Male
Genital Diseases, Female
Immune System Diseases